Histalim innovates in the fight against cancer

What is Histalim’s field of expertise? The company develops new therapies, such as immunotherapy, that are used increasingly to treat cancer. Providing histology and image analysis services, the Montpellier company develops biomarkers that identify tumor immune profiles.

“Immuno-profiling is a precise medical tool that makes it possible to understand where a given cancer’s immune barriers are located and determine which type of immunotherapy could offer the most appropriate treatment,” explains Jean-Philippe Coton, who founded Histalim in 2005. 

“These new treatments are a major focus for the pharmaceutical industry,” adds the CEO.

His company also performs clinical trials each year to validate protocols via multiplex immunohistochemistry, a high-precision imaging technology that shows multiple biomarkers from a single histological cross-section. Histalim plans to continue developing this activity.